Study Overview: This study aims to improve the use of germline genetic testing for patients with certain types of cancer like breast, pancreatic, or colorectal cancer. Germline genetic testing checks for inherited gene changes that can increase the risk of cancer. This is important because finding these changes can help doctors choose the best treatments and can also help family members know if they might be at risk too.
- **Duration:** The study will be conducted over three 6-month phases with a follow-up period.
- **Participants:** The focus is on oncology care teams, including doctors and nurses who work with cancer patients.
- **Methods:** Different strategies like education and support will be used to encourage more testing.
Why Participate? By taking part in this study, care teams can help make genetic testing more accessible, potentially leading to better care for patients. The study will look at how well these strategies work and if they help more patients complete testing. This could lead to early detection and better management of cancer. The study will also collect data from electronic health records and feedback from healthcare providers to see how well the strategies are working and to make future improvements.